...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: I'll believe
 whatever deal/statements Don speaks about when we see it on paper via a NR.
 
 I'll believe better things are ahead once we see the market/investors/expertmarlet start "backing their trucks up" as has been suggested.
 
Zen closed up 25% to .20US Friday - if things are truly lining up I see no reason why this stock won't climb to where the most recent PP's were done(close to or around $1.00US) & in short order. If we are indeed clear for launch this shouldnt be a problem.
 
I want & need to believe that this isn't just more chatter. After all we have seen & heard over the decades that never happened im still quite skeptical.
 
Lets  see what happens between now & xmass. Proofs in the pudding!
 
Make me a BELIEVER Don
 
GLTA
Share
New Message
Please login to post a reply